Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Emtricitabine for Prevention of Vertical Transmission of HBV in Chinese Pregnant HBsAg Positive Patients

NCT02327715 is registered in ClinicalTrials.gov with Asian-Pacific Alliance of Liver Disease, Beijing as lead sponsor.

NCT NCT02327715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02327715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Emtricitabine for Prevention of Vertical Transmission of HBV in Chinese Pregnant HBsAg Positive Patients
Lead sponsor
Asian-Pacific Alliance of Liver Disease, Beijing
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2015
Completion date
July 31, 2016
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, chronic, pregnancy